|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/47 | |
| A61K 39/00 | |||
| A61K 39/395 | |||
| A61P 25/28 | |||
| A61P 37/04 | |||
| C07K 16/18 | |||
| C12N 15/13 | |||
| G01N 33/53 | |||
| C07K 7/06 | |||
| C07K 7/64 | |||
| G01N 33/68 | |||
| A61K 45/06 |
| (11) | Number of the document | 3056510 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15203261.1 |
| Date of filing the European patent application | 2011-03-03 | |
| (97) | Date of publication of the European application | 2016-08-17 |
| (45) | Date of publication and mention of the grant of the patent | 2018-10-03 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 310167 P | 2010-03-03 | US |
| (72) |
CASHMAN, Neil R, CA
|
| (73) |
THE UNIVERSITY OF BRITISH COLUMBIA,
103 - 6190 Agronomy Road, Vancouver, British Columbia V6T 1Z3,
CA
|
| (54) | OLIGOMER-SPECIFIC AMYLOID BETA EPITOPE AND ANTIBODIES |
| OLIGOMER-SPECIFIC AMYLOID BETA EPITOPE AND ANTIBODIES |